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Volume 60, Number 1 Abstracts 265rates for up to 15 years. Screening was associated with more overall and
elective surgeries and fewer emergency operations and lower 30-day opera-
tive mortality rates at up to 10- to 15-years of follow-up. One RCT
involving 9342 women showed that screening had no beneﬁt on AAA
related mortality or all-cause mortality rates in women.
Comment: This updated review by the USPSTF reconﬁrms the value
of aneurysm screening in older males. The data remains limited by the fact
that the trials included for this evaluation consists mostly of white men
outside the United States and there’s little information about subgroups
and rescreening. Screening for abdominal aortic aneurysm thus far remains
the only vascular condition in which the USPSTF has found beneﬁt for the
screening process, with this group previously coming out against screening
for peripheral arterial disease and screening for carotid artery stenosis.
Optimizing the Outcome of Vascular Intervention for Takayasu’s
Arteritis
Perera AH, Youngstein T, Gibbs RGJ, et al. Br J Surg 2014;101:43-50.
Conclusions: Perioperative assessment in a detailed fashion will
improve vascular outcomes of Takayasu’s arteritis with focus on measure-
ment of disease activity and using optimal immunomodulatory therapy
before and after the procedure.
Summary: Takayasu’s arteritis (TA) is a large-vessel vascular arteritis
characterized by granulomatous changes of the aorta and its major branches.
The typical patient is under 40 years of age and the Takayasu’s process results
in stenotic or occlusive lesions predisposed to symptoms of end-organ
ischaemia such as claudication or hypertension. Less commonly there is
medial degeneration and aneurysmal dilation. There are numerous imaging
modalities including [18 F] ﬂuorodeoxyglucose combined positron emission
and computed tomography (18F-FDG-PET-CT), Doppler ultrasonography,
magnetic resonance angiography or CT angiography that have the ability to
identify prestenotic disease, and to reveal the extent of arterial injury and
perhaps to help monitor the response to immunomodulatory therapy (Ma-
son JC, Nat Rev Rheumatol 2010;6:406-415). Poor outcomes in patients
with Takayasu’s arteritis have been attributed to delayed diagnosis, which
may result from a lack of awareness of the condition, as well as late adminis-
tration of adequate medical treatment. Poor outcomes also can result from
inadequate patient selection and suboptimal timing of vascular intervention.
The authors sought to analyze, retrospectively, a cohort of patients with
Takayasu’s arteritis in the UK, to try to identify and analyze outcomes of
open surgical and endovascular interventions and to report concurrent use
of imaging before and after the procedure and also to investigate the impact
of perioperative immunosuppressive therapy. This was a retrospective view of
patients with Takayasu’s arteritis referred from 2001 and 2012 to a single ter-
tiary care center. 97 patients with Takayasu’s arteritis were seen. Immuno-
suppression was required in 87 patients (90%). Thirty-seven (38%)
underwent 64 procedures: 27 patients underwent 33 open surgical proce-
dures and 20 patients had 31 endovascular procedure. After a median
follow-up of 6 years, the overall success rate was 79% for open surgery
(mean graft patency, 9.4 years) and 52% for endovascular procedures (P ¼
.035). Procedural failure was reduced in patients receiving perioperative
immunosuppression, particularly in those with endovascular procedures (P
¼ .001). Clinical examination, measurement of acute-phase reactants and
combination non-invasive imaging including Doppler ultrasonography,
[18F] ﬂuorodeoxyglucose combined positron emission and computed to-
mography (CT), magnetic resonance angiography and CT angiography
were used to identify arterial lesions, establish the diagnosis and monitor
treatment outcomes. Overall and cumulative intervention failure rate was
34% (22 of 64), 7 (21%) of the 33 open and 15 (48%) of the 31 endovascular
procedures. Analyses of the outcomes of intervention suggested signiﬁcantly
improved results in those who received immunosuppression before an endo-
vascular intervention (P ¼ .001), but not necessarily for those that received
an open surgery (P ¼ .095). Six of the seven failed open procedures were
done in patients who did not receive preoperative medical therapy. 14 of
15 open procedures in patients who received medical therapy achieved
long-term patency (93%). In the endovascular group, 13 or the 15 failed pro-
cedures were not associated with preoperative immunomodulatory therapy.
However, 12 of 14 endovascular procedures associated with preoperative
immunomodulatory therapy remained patent.
Comment: In general, immunosuppression at the time of surgery is
considered a potential cause of postoperative complications. In this series,
however, no patient receiving immunosuppressive therapy at the time of
their procedure had a life-threatening complication and there were no dele-
terious effects of immunosuppressive therapy on surgical recovery or wound
infection noted. The data here would suggest that active suppression of the
Takayasu disease process at the time of therapy with immunosuppression
should be strongly considered with the beneﬁts of improved reconstruction
patency outweighing the adverse effects of the immunosuppression in the
perioperative period.Introduction of Surgical Safety Checklists in Ontario, Canada
Urbach DR, Govindarajan A, Saskin R, et al. N Engl J Med
2014;370:1029-38.
Conclusions: Implementation of surgical safety checklists in Ontario,
Canada did not result in signiﬁcant reductions of operative mortality or
complications.
Summary: In 2009, a study was published that suggested the imple-
mentation of a 19-item World Health Organization (WHO) Surgical Safety
Checklist substantially reduces the rate of surgical complications, from
11.0% to 7.0% in that study, and reduced the rate of in-hospital deaths
from 1.5% to 0.8% (Haynes AB et al, N Engl J Med 2009;360:491-9).
Largely as a direct result of that study surgical safety checklists were imple-
mented in thousands of hospitals world-wide in an effort to reduce in-hos-
pital complications and mortality. However, studies of the effects of
implementations of these checklists have been observational and limited
to small numbers of centers, and frequently have not evaluated patient out-
comes and have not showed the magnitude of effectiveness found in the
WHO study. Only studies including team training, and more comprehen-
sive safety systems that included multiple checklists have shown effectiveness
similar to those seen in the WHO study (Young-Xu Y et al, Arch Surg
2011;146:1368-73, and de Vries EN et al, N Engl J Med
2010;363:1928-37). In Ontario, Canada the Ministry of Health and
Long-Term Care mandated public reporting of adherence to surgical safety
checklists for hospitals beginning in July 2010. The authors felt this rapid
implementation of surgical safety checklists in Ontario was a natural exper-
iment to evaluate the effectiveness of checklist implementation at the pop-
ulation level in typical practice settings. They surveyed all acute care
hospitals in Ontario to determine when surgical safety checklists were adop-
ted. Using administrative health data they then compared operative mortal-
ity and rates of surgical complications linked to hospital stay and rates of
hospital readmission and urgent or emergency department visits within
30 days after discharge among patients undergoing a variety of surgical pro-
cedures, before and after adoption of the checklists. During the 3-month
period before and after adoption of the surgical safety checklists a total of
101 hospitals performed 109,341 and 106,370 procedures, respectively.
Adjusted risk of death during a hospital stay within 30 days after surgery
was 0.71% (95% CI, 0.66-0.76) before implementation of a surgical check-
list and 0.65% (95% CI, 0.60-0.70) afterward (odds ratio, 0.91; 95% CI,
0.80-1.03; P ¼ .13). Adjusted risk of surgical complications was 3.86%
(95% CI, 3.76-3.96) before implementation and 3.82% (95% CI, 3.71-
3.92) afterward (odds ratio, 0.97; 95% CI, 0.90-1.03; P ¼ .29).
Comment: The absence of effect of checklist implementation in this
study may reﬂect many possibilities. Perhaps published evidence on the ef-
ﬁcacy of implementing checklists within hospitals that participate in safety
research is not generalizable to all hospitals. Surgical safety checklists may
also be less effective in practice than suggested by existing literature.
Perhaps, as the authors point out, there is a Hawthorne Effect with a ten-
dency to perform better when work is under scrutiny that may explain the
strong effect of surgical safety checklists in studies in which hospitals where
workers were aware of the intervention under study. There may also be pub-
lication bias in that hospital based studies showing improvements in out-
comes after checklist implementation are more likely to be published than
negative studies. Also, as noted above, there may also be a greater effect
of surgical safety checklists when intensive team training is utilized along
with implementation of the checklists, and where there is better monitoring
compliance. Nevertheless, it does appear that the effectiveness of surgical
safety checklists, which have never been evaluated in a randomized control
trial, perhaps should undergo greater scrutiny.
Mortality From Ruptured Abdominal Aortic Aneurysms: Clinical
Lessons From a Comparison of Outcomes in England and the USA
Karthikesalingam A, Holt PJ, Vidal-Diez A, et al. Lancet 2014;383:963-9.
Conclusions: In-hospital survival from ruptured abdominal aortic
aneurysm (rAAA), intervention rates, and use of endovascular repair are
lower in England than in the USA. In England and the USA, lowest mor-
tality for rAAA is seen in teaching hospitals with larger bed capacities and
doing a greater proportion of cases with endovascular repair.
Summary: Outcomes of patients with rAAA vary by country. There
are likely modiﬁable technical, organizational and hospital related factors
that play important roles in patient care and outcomes of rAAA. Such vari-
ables merit further study to help optimize service delivery and improve pa-
tient outcomes for care of what is otherwise a fatal disease. In this paper, the
authors compare data from the Hospital Episode Statistics for England and
the Nationwide Inpatient Sample for the USA for patients admitted to hos-
pital with rAAA from 2005 to 2010. Primary outcomes were in-hospital
mortality, mortality after intervention, and decision to follow noncorrective
treatment. In-hospital mortality and the rates of non-corrective treatment
